Charles River Apr 30, 2026 Charles River Laboratories Stock: Q1 2026 Earnings Release Scheduled for April 30 - AD HOC NEWS
Charles River Apr 23, 2026 Charles River Laboratories International Drops 7.2% Amid Sector-Wide Selling - AlphaStreet
Charles River Apr 21, 2026 Charles River Introduces First Rapid Animal-Free Bacterial Endotoxin Test - BioPharma APAC
Charles River Apr 10, 2026 Charles River flows into Boston to help AHA bridge cardiovascular health divide - Fierce Pharma
Charles River Mar 5, 2026 Charles River Laboratories International (CRL) Faces Biotech R&D Spending Headwinds - Yahoo Finance
FierceBiotech Feb 25, 2026 Charles River sells manufacturing and discovery businesses to fulfill promised pivot
Charles River Feb 25, 2026 Charles River sells manufacturing and discovery businesses to fulfill promised pivot - Fierce Biotech
Charles River Feb 9, 2026 Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays - News-Medical
Charles River Feb 4, 2026 Charles River Laboratories to Close Maryland Cell Therapy Site, Cut 20 Jobs - Contract Pharma
Charles River Feb 3, 2026 Charles River to close cell therapy CDMO site, lay off 20 staffers - Fierce Biotech
FierceBiotech Jan 28, 2026 Reducing animal testing 'an evolution and not a revolution' for life sci R&D, Charles River's incoming CEO says
FierceBiotech Jan 8, 2026 Longtime Charles River leader Jim Foster to retire, with COO set to take the helm
Endpoints News Dec 29, 2025 ASK Pharm makes China rights deal; Unicycive resubmits kidney drug after CRL